RELATING TOQuality Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations
Quality Agreement for CGMP Testing ServicesQuality Agreement • January 24th, 2019
The Purpose of this Quality Agreement is to establish, clarify, and communicate quality expectations related to CGMP testing. This agreement shall apply to all samples submitted for testing. It is the responsibility of the Client to inform NJ LABS, utilizing the NJ LABS sample submission form, and by contacting NJ LABS’s Business Development group, of any special testing requirements. When samples are submitted to NJ LABS, they are designated as CGMP. This Agreement shall remain in effect until cancelled with notice by either party.
Agreement number /20XXQuality Agreement • December 17th, 2020
Incorporated in the Business Register of District Court Bratislava I., Section Po, Insert no. 312/B “(hereinafter referred to as the “Infrastructure Manager” or “ŽSR“)“
Quality Agreement and award of a Quality Label to enterprises within the jurisdiction of the Samaria National Park Management Body (SNP-MB), in agreement with its terms and conditions.Quality Agreement • February 13th, 2017
The establishment of certification procedures leading to the award of quality labels has for many years been a widespread practice (e.g. Italy, France). There, the national and local authorities (ministries, chambers, etc.), having come to an early realisation of the importance and role of quality in the development of local products and tourism services, established special labels for their certification.
ContractQuality Agreement • March 29th, 2021
ContractQuality Agreement • April 4th, 2022
Smlouva o jištění jakosti Quality agreement 1. Novartis s.r.o. 1. Novartis s.r.o. se sídlem Na Pankráci 1724/129, PSČ 140 00Praha 4, Nusle registered office at Na Pankráci 1724/129,Post code 140 00, Prague 4, Nusle Zastoupená Emilie Marie Grand-Perret,jednatelka represented by Emilie Marie Grand-Perret,executive director IČ: 64 57 59 77 ID no.: 64 57 59 77 DIČ: CZ 64 57 59 77 VAT ID no.: CZ 64 57 59 77 Bankovní spojení: Bank connection: Zapsaná v obchodním rejstříku: Městského soudu v Praze, oddíl C, vložka 41352 Registered in the Commercial Register: Municipal Court in Prague, section C, file41352 (dále jen „Novartis“) (hereinafter referred to as „Novartis“) A and 2. Fakultní nemocnice Královské Vinohrady 2. Fakultní nemocnice Královské Vinohrady sídlo Šrobárova 1150/50, 100 34 Praha 10,Česká republika registered office Šrobárova 1150/50, 100 34Prague 10, Czech Republic zastoupená Prof. MUDr. Petr Arenberger,DrSc, MBA, FCMA, ředitel represented by Prof. MUDr. Petr Arenberger, DrSc, MB
Quality Agreement betweenQuality Agreement • February 5th, 2020
Change and Deviation ManagementQuality Agreement • May 8th, 2020
This experience makes us the perfect partner for high quality raw materials with comprehensive change and deviation management, ideal for the highly regulated field of cosmetics.
ContractQuality Agreement • December 15th, 2022
QUALITY AGREEMENTQuality Agreement • April 12th, 2022
QUALITY AGREEMENT No. 014180-1NOHL-00Quality Agreement • July 7th, 2015 • Gensight Biologics • Biological products, (no disgnostic substances)
This quality agreement (the “Quality Agreement”) is made and entered into as of 10th June 2014, by and between GENETHON, a non-profit organization organized under the laws of France (SIRET: 40218752000018), with its principal place of business at 1bis, rue de l’Internationale, 91002 Evry Cedex, France (“GENETHON”), and GENSIGHT-BIOLOGICS SA, a corporation organized under the laws of France, registered with the Lyon Trade and Company Registry under number B 751 164 757 (SIRET: 75116475700013), with its principal place of business at 74 rue du Faubourg Saint Antoine, 75012 Paris, France (“GENSIGHT”), (each of GENSIGHT and GENETHON a “Party” individually and collectively the “Parties”).
The Chilmington Green ‘Quality Agreement’:Quality Agreement • September 26th, 2013
This ‘Quality Agreement’ has been entered into by the developers at Chilmington Green and the Borough Council. It is not a formal legal agreement but is a statement of intent and a set of practical steps that the parties are committed to with the intention that these will apply not just to the current developers but also to future house-builders working at Chilmington Green. It will guide progress towards our shared goal of creating a vibrant community and a very special place. The Agreement will need to be kept under regular review and additional development costs arising may need to be reflected in discussions about the overall contributions package so that the project remains viable.
Quality AgreementQuality Agreement • July 31st, 2019
QUALITY AGREEMENTQuality Agreement • February 11th, 2023
Quality Agreement TAV-Medical Ltd and PALTOP Ltd Revision 1Quality Agreement • October 5th, 2023 • Capstone Dental Pubco, Inc. • Dental equipment & supplies
This document defines the requirements that must be met by the Contract Manufacturer (CM) & Supplier ‘TAV-Medical’ (herby:“Tav) organization in the conduct of the applicable production activities related to the TAV-Medical & Paltop products. These requirements have been established by Paltop to fulfill all quality, regulatory, statutory, performance, safety, and effectiveness requirements specific to this medical product, and to fulfill Paltop responsibility as a medical device manufacturer.
This Quality Agreement is by and between ZF Steering Systems, LLC,Quality Agreement • February 23rd, 2018
ContractQuality Agreement • December 1st, 2009
Adresse Lieferant:Address Supplier: KOSTAL CR, spol. s r.o.Černín 89267 51 Zdice QualitätssicherungsvereinbarungQuality Agreement Ausgabe / Edition : 02gültig ab : 01.06.2007valid since : Warengruppe Commodity Group 406092 / 409092 / 410092 / Aluminium - Zink - Mg Gußteile406092 / 409092 / 410092 / Aluminium – Zinc – Mg- cast part Abteilung:Department: AQS Gültig für: Valid for: Alle Lieferumfänge, die für KOSTAL Produkte bestimmt sind. All shipments, which are designated for KOSTAL´s products. Reichweite: Scope: Lieferant weltweit, seine beauftragten Unterlieferanten einschließlich Konzerngesellschaften. Supplier world wide, his assigned sub supplier and affiliated companies. Die Prozessfähigkeit oder entsprechende qualitäts- sichernde Maßnahmen sind nach A/B/C über den gesamten Produktionszeitraum nachzuweisen.Maßgeblich sind die entsprechenden Normen, Standards, Datenblätter in der jeweils gültigen Process capability or equivalent quality activities must be available according to
ContractQuality Agreement • January 25th, 2022
Apical Quality AgreementQuality Agreement • January 4th, 2022 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus
ContractQuality Agreement • January 25th, 2021
Споразумение за осигуряване на качествотоQuality agreement form SYS 06.00.15 Electronic assembling Systems – Components - Sets Published: 10.05.06 Telefon : 00359 2 9208595Telefax : 00359 2 9208596 Revision: 01-2021 Mail : Syscoset@syscoset.com Homepage: www.syscoset.com Quality agreement Between SYSCOSET ELECTRONICS LTD.Filip Kutev 7 , Hladilnika Bg – 1407 – Sofia Bulgaria(Purchaser) and (Supplier) ---------------------------------, further called supplier, if the goods are shipped from a certain facility of the supplier, the address of this facility has to be mentioned below.
INDICATES MATERIAL THAT HAS BEEN OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED. ALL SUCH OMITTED MATERIAL HAS BEEN FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933,...Quality Agreement • May 24th, 2018 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations
The Parties wish to further define their individual and collective responsibilities as to the quality aspects of the Product or Service to ensure compliance with applicable current Good Manufacturing Practices (cGMPs), applicable regulatory submissions for the Product, applicable regulatory submissions for the Services, other applicable regulatory requirements, and XERIS s requirements as specified by XERIS (the “XERlS Requirements”).
Quality AgreementQuality Agreement • June 4th, 2024 • Catheter Precision, Inc. • Surgical & medical instruments & apparatus
A Quality Agreements projectQuality Agreement • December 1st, 2022
Experiment with Active Learning Spaces (ALS) that are necessary for active learning, the didactic method supporting the educational vision of the University of Groningen.
CONFIDENTIAL TREATMENT REQUESTED QUALITY AGREEMENTQuality Agreement • May 10th, 2006 • Avanir Pharmaceuticals • Pharmaceutical preparations
WHEREAS Patheon and Avanir are currently negotiating a manufacturing services agreement (the "MSA”), to which this Quality Agreement will form part of, wherein Patheon will agree to provide pharmaceutical manufacturing services in respect of certain Products (as described in Schedule A hereto);
QUALITY AGREEMENTQuality Agreement • March 8th, 2013
QUALITY AGREEMENT – FONDERIA TARONIQuality Agreement • September 22nd, 2017
This procedure aims to successful manufacture of components and subassemblies provided by SUPPLIER and purchased by FONDERIA TARONI. The responsibility matrix below defines and deals with the necessary documentation and responsibilities.
Quality AgreementQuality Agreement • February 15th, 2013
Quality Agreement for CGMP Testing ServicesQuality Agreement • July 26th, 2023
The Purpose of this Quality Agreement is to establish, clarify, and communicate quality expectations related to CGMP testing. This agreement shall apply to all samples submitted for testing. It is the responsibility of the Client to inform NJ LABS, utilizing the NJ LABS sample submission form, and by contacting NJ LABS 's Business Development group, of any special testing requirements. When samples are submitted to NJ LABS, they are designated as CGMP. This Agreement shall remain in effect until cancelled with notice by either party.
Quality AgreementQuality Agreement • March 12th, 2018
The Purpose of this Quality Agreement is to establish, clarify, and communicate quality expectations related to cGMP testing. This agreement shall apply exclusively to samples submitted for testing that must be tested in compliance with cGMP guidelines. It is the responsibility of the Client to inform ARL, utilizing the ARL sample submission form, and by contacting ARL’s Business Development group, if the requested testing is to be conducted per cGMP guidelines. When samples are submitted to ARL and designated as cGMP and a quote is in place that indicates cGMP testing requirements, than the testing will be conducted under cGMP conditions. This Agreement shall remain in effect until cancelled with notice by either party.
Distributor/Importer Quality Agreement Under In Vitro Diagnostic Medical Device Regulation (EU) 2017/746Quality Agreement • December 19th, 2019
This agreement defines the Quality Agreement between the parties identified below. It defines the commitment both parties make to ensure that their respective products and services satisfy the quality and regulatory requirements called out in this agreement. Both parties agree to cooperate in the success of this agreement.
ContractQuality Agreement • August 6th, 2019
ContractQuality Agreement • November 18th, 2014
For Fasteners in the Automotive IndustryQuality Agreement • June 23rd, 2023
QUALITY AGREEMENT Between BriaCell Therapeutics Corp 820 Heinz Avenue Berkley, CA 94710 And Catalent Pharma Solutions, LLC 14 Schoolhouse Road Somerset, NJ 08873, US (represented by its signing affiliates) For Oral Drug Delivery and Clinical Supply...Quality Agreement • August 30th, 2019 • BriaCell Therapeutics Corp. • Pharmaceutical preparations
This is a Quality Agreement for ORAL DRUG DELIVERY and CLINICAL SUPPLY SERVICES provided by Catalent Pharma Solutions. This Quality Agreement defines the duties of Catalent Pharma Solutions, LLC (CATALENT/CPS) and BriaCell Therapeutics Corp (CUSTOMER) for the supply of clinical trial materials.
QUALITY AGREEMENTQuality Agreement • December 26th, 2022
